EBMT NEWSLETTER | September 2017 | Volume 58 - Issue 4

Important dates
New Horizons in the Management of ADA-SCID, led by Andrew Gennery, Robbert Bredius and Bobby Gaspar, is a free resource designed to educate healthcare professionals who are presented with Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) patients.

New Horizons in the Management of ADA-SCID, focuses on the biology of the disease, how to screen for it, and current and emerging treatments.
Aimed at Immunologists, Gene and Cell Therapy Clinicians, Transplant Specialists, Paediatricians and Haematologists, the site provides:
  • Interviews with Marina Cavazzana and Arjan Lankester
  • Summaries of the latest research
  • Free access to full-text articles
  • Full editorials covering:
Biology of ADA-SCID
Currently approved and standard of care therapies for ADA-SCID
Newborn screening

And coming soon:
  • An on-demand webcast
  • Interactive patient cases
  • More expert interviews 
Please visit New Horizons in the Management of ADA-SCID, today.
Bookmark and Share